Climb Bio (CLYM) Change in Acquisitions & Divestments (2022 - 2026)

Climb Bio (CLYM) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $31.9 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 99.37% year-over-year to $31.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $127.0 million (up 452.18% YoY) and the FY2025 annual result came in at $111.1 million, up 435.41% from the prior year.
• Change in Acquisitions & Divestments grew to $31.9 million in Q1 2026, from $30.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $55.3 million in Q3 2022 to a low of $7.0 million in Q4 2024.
• A 5-year average of $27.6 million and a median of $25.5 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments slumped 80.95% — and 2025, when it soared 336.26%.
• Tracing CLYM's Change in Acquisitions & Divestments over 5 years: stood at $21.0 million in 2022, then jumped by 75.06% to $36.7 million in 2023, then tumbled by 80.95% to $7.0 million in 2024, then jumped by 336.26% to $30.5 million in 2025, then rose by 4.47% to $31.9 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $31.9 million (Q1 2026), $30.5 million (Q4 2025), and $39.1 million (Q3 2025), per Business Quant data.